Scientists and doctors internationally are trying to develop a more virtuously regulated method of distribution for the COVID-19 Vaccine when it becomes available because there will be a unavailability at the launch of the process. The connoisseurs are suggesting the Impartial Precedence Model, which consists of treating people at risk of untimely death, health care workers, the aging, and those with irretrievable health effects. To use this standard of distribution would not be honestly fair to those individuals. It is honorable for people with diabetes, corpulence, and those who live in abject poverty-stricken neighborhoods be added as a primacy under this Good Priority Model.
There has been news about a similar way of distribution across the globe for COVID-19 Vaccines when made satisfactorily for human intake. The problem with that has been the experts are barring numerous persons that are undergoing difficulties. They are planning a trio-phase plan that they contemplate to be honest and impartial.
Table of Contents
1. Introduction
2. Main Idea
3. Conclusion
Objectives and Topics
The primary objective of this paper is to critically evaluate current global distribution models for COVID-19 vaccines, arguing that existing frameworks fail to adequately protect vulnerable populations such as individuals with diabetes, obesity, and those living in poverty.
- Critique of the Impartial Precedence Model
- Ethical considerations in vaccine allocation
- Impact of comorbidities like diabetes and obesity
- Socioeconomic factors and health equity
- Limitations of current prioritization phases
Excerpt from the Book
Introduction:
Scientists and doctors internationally are trying to develop a more virtuously regulated method of distribution for the COVID-19 Vaccine when it becomes available because there will be a unavailability at the launch of the process. The connoisseurs are suggesting the Impartial Precedence Model, which consists of treating people at risk of untimely death, health care workers, the aging, and those with irretrievable health effects (University of Pennsylvania. School of Medicine, 2020). To use this standard of distribution would not be honestly fair to those individuals. It is honorable for people with diabetes, corpulence, and those who live in abject poverty-stricken neighborhoods be added as a primacy under this Good Priority Model.
There has been news about a similar way of distribution across the globe for COVID-19 Vaccines when made satisfactorily for human intake. The problem with that has been the experts are barring numerous persons that are undergoing difficulties. They are planning a trio-phase plan that they contemplate to be honest and impartial.
Summary of Chapters
1. Introduction: This chapter outlines the initial proposal for a global vaccine distribution strategy and critiques the exclusion of vulnerable groups within the suggested framework.
2. Main Idea: The section details the specific flaws in the proposed three-phase priority model, highlighting ethical inconsistencies and the oversight of critical health risk factors like diabetes and obesity.
3. Conclusion: The summary emphasizes the failure of current national strategies to protect those most exposed to the pandemic, advocating for a more inclusive approach to vaccine prioritization.
Keywords
COVID-19, Vaccine Distribution, Ethical Framework, Impartial Precedence Model, Diabetes, Obesity, Health Equity, Socioeconomic Factors, Vulnerable Populations, Public Health, Pandemic, Prioritization, Global Health, Clinical Vulnerability, Social Justice
Frequently Asked Questions
What is the primary focus of this publication?
This paper examines the ethical framework surrounding the global distribution of COVID-19 vaccines and evaluates whether proposed prioritization models sufficiently protect vulnerable populations.
What are the central themes discussed?
The central themes include vaccine allocation ethics, the role of comorbidities such as diabetes and obesity in mortality risk, and the impact of socioeconomic status on health access during a pandemic.
What is the core research question or objective?
The objective is to challenge the fairness of the proposed "Impartial Precedence Model" and argue for the inclusion of high-risk, low-income, and chronically ill individuals in early vaccination efforts.
Which scientific methodology is employed?
The author uses a critical analysis approach, reviewing existing ethical frameworks and epidemiological data regarding mortality rates associated with COVID-19 and pre-existing conditions.
What topics are covered in the main body of the work?
The main body critiques the three-phase distribution plan, analyzes statistics regarding diabetes and obesity-related outcomes, and discusses the challenges faced by hardship-stricken populations.
What are the characterizing keywords of the work?
Key terms include COVID-19, Vaccine Distribution, Ethical Framework, Diabetes, Obesity, Health Equity, and Vulnerable Populations.
Why does the author consider the "Impartial Precedence Model" unethical?
The author argues it is unethical because it prioritizes certain groups while ignoring the high mortality risk faced by individuals with chronic illnesses like diabetes and those living in poverty-stricken areas.
How does the author relate socioeconomic status to the vaccine rollout?
The author highlights that individuals in low-income brackets often work jobs that force them to choose between health safety and financial survival, making them particularly vulnerable to the virus and deserving of priority status.
- Quote paper
- Dr. Franklin Atadja (Author), 2020, Global Distributions for COVID-2019 Vaccines. A Short Essay about Health Concepts, Munich, GRIN Verlag, https://www.grin.com/document/1003090
